Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan - a cohort study

Oncotarget. 2016 Apr 19;7(16):22948-59. doi: 10.18632/oncotarget.8312.

Abstract

Curative surgical resection (CSR) remains the most effective therapeutic intervention for patients with hepatocellular carcinoma (HCC); however, frequent post-surgical recurrence leads to high cancer related mortality. This study aimed to clarify the role of body mass index (BMI) and serum cholesterol level in predicting post-surgical outcomes in HCC patients after CSR. A total of 484 HCC patients including 213 BMIhigh and 271 BMIlow patients were included. Overall survival (OS) and recurrence-free survival (RFS) rates were examined in patients with differential BMI and serum cholesterol level. The analysis showed that significant different 1-, 3- and 5-year cumulative OS rates (P-value=0.015) and RFS rate (P-value=0.010) between BMIlow and BMIhigh patients. Further analysis in groups with differential serum cholesterol levels among BMIlow and BMIhigh patients indicated that the BMIlow/Chollow patients exhibited the significant lower cumulative OS and RFS rates in comparison with the remaining subjects (P-value=0.007 and 0.039 for OS and RFS rates, respectively). In conclusion, the coexistence of low BMI and low serum cholesterol level could serve as prognostic factors to predict post-operative outcomes in HCC patients undergoing surgical hepatectomy.

Keywords: body mass index; curative surgical resection; hepatocellular carcinoma; prognostic indicator; serum cholesterol level.

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / analysis
  • Body Mass Index*
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / pathology*
  • Cholesterol / blood*
  • Cohort Studies
  • Female
  • Hepatectomy
  • Humans
  • Kaplan-Meier Estimate
  • Liver Neoplasms / complications
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology*
  • Male
  • Middle Aged
  • Obesity / complications*
  • Prognosis
  • Risk Factors
  • Taiwan
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Cholesterol